Research study Program year 2024 Source: CMS Open Payments

Ngam-13

Research payments

$743,924

81 payments

Through program year 2024, $743,924 in research payments was reported against Ngam-13, across 81 payments, paid by Octapharma USA, Inc..

Paid by: Octapharma USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$341,045	23
2023	Research	$187,019	27
2022	Research	$201,353	25
2021	Research	$12,908	5
2019	Research	$1,600	1

Breakdown

Who paid Research payments · program years 2019–2024

Octapharma USA, Inc. $743,924 81 payments

Who received the money Research payments · program years 2019–2024

Lucile Packard Children's Hospital Stanford University Organisation paid for research $119,276 6 payments
Kyle Williams Child & Adolescent Psychiatry · Boston, MA $104,982 8 payments
Arkansas Children's Research Institute Organisation paid for research $93,527 13 payments
University of Arizona Organisation paid for research $75,528 6 payments
Jennifer Frankovich Pediatric Rheumatology · Palo Alto, CA $54,067 1 payment
Immunoe International Research Centers Organisation paid for research $43,955 3 payments
Dartmouth-Hitchcock Clinic Organisation paid for research $42,629 6 payments
Stanford University Organisation paid for research $41,526 6 payments
Michael Daines Pediatric Allergy/Immunology · Tucson, AZ $38,632 3 payments
Childrens Postinfectious Autoimmune Encephalopathy (Cpae) Center Of Excellence - University Of Ariz Organisation paid for research $36,881 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.